Latest P53 Stories
Interested in antioxidants? They protect us against aging and cancer.
- More than 50 abstracts highlight breadth and depth of Novartis Oncology pipeline and ability to test various combinations early to target multiple pathways EAST HANOVER, N.J., April 3, 2014
Since the dawn of civilization people were searching for clues to longevity and trying to extend human lifespan.
Studies Identify PI3K Pathway Combinations and MYC Driven Cancers SAN DIEGO and NEW TAIPEI CITY, Taiwan, March 27, 2014 /PRNewswire-iReach/ -- Senhwa Biosciences, Inc.
Clinical and Regulatory Plans for Two Lead Products Announced SAN DIEGO, Feb.
Johns Hopkins scientists say a previously known but little studied chemical compound targets and shuts down a common cancer process.
A new study led by University of Kentucky researchers suggests that activating the tumor suppressor p53 in normal cells causes them to secrete Par-4, another potent tumor suppressor protein that induces cell death in cancer cells.
A potential new cancer therapy works by “turning on” a powerful natural tumor suppressor. Raleigh, NC (PRWEB) December 24, 2013 A new study published
- To fire mitraille at.